Gastrointestinal hemorrhage after acute ischemic stroke and its risk factors in asians

European Neurology

Volumn 62, Issue 4, 2009, Pages 212-218

  Hsu, Huan Lin ^a,d   Lin, Ya Hui ^a   Huang, Yen Chu ^a   Weng, Hsu Huei ^b,d   Lee, Meng ^a   Huang, Wen Yi ^c   Lee, Jiann Der ^a,d  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b Chiayi Branch

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Asians; Gastrointestinal hemorrhage; Ischemic stroke; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; STEROID; WARFARIN;

ACUTE DISEASE; AGE DISTRIBUTION; AGED; ARTICLE; ASIAN; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; COLON ULCER; DIGESTIVE SYSTEM ULCER; DISEASE ASSOCIATION; DISEASE SEVERITY; DUODENUM ULCER; ESOPHAGUS ULCER; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; LENGTH OF STAY; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEPSIS; STOMACH ULCER; STROKE; TAIWAN;

AGE FACTORS; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN INFARCTION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTORS; TAIWAN;

EID: 67650706801     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000229018     Document Type: Article

References (31)

1. Huang ZS, Chiang TL, Lee TK: Stroke prevalence in Taiwan: findings from the 1994 National Health Interview Survey. Stroke 1997; 28: 1579-1584.
2. Chambers BR, Norris JW, Shurvell BL, Hachinski VC: Prognosis of acute stroke. Neurology 1987; 37: 221-225.
3. Johnston KC, Li JY, Lyden PD, Hanson SK, Feasby TE, Adams RJ, Faught RE Jr, Haley EC Jr: Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial: RANTTAS investigators. Stroke 1998; 29: 447-453.
4. Wijdicks EF, Fulgham JR, Batts KP: Gastrointestinal bleeding in stroke. Stroke 1994; 25: 2146-2148.
5. Davenport RJ, Dennis MS, Warlow CP: Gastrointestinal hemorrhage after acute stroke. Stroke 1996; 27: 421-424.
6. Misra UK, Kalita J, Pandey S, Mandal SK: Predictors of gastrointestinal bleeding in acute intracerebral haemorrhage. J Neurol Sci 2003; 208: 25-29.
7. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C: Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337: 1521-1526.
8. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-1655.
9. Idjadi F, Robbins R, Stahl WM, Essiet G: Prospective study of gastric secretion in stressed patients with intracranial injury. J Trauma 1971; 11: 681-688.
10. Lewis EA: Gastroduodenal ulceration and haemorrhage of neurogenic origin. Br J Surg 1973; 60: 279-283.
11. Dimant J, Grob D: Electrocardiographic changes and myocardial damage in patients with acute cerebrovascular accidents. Stroke 1977; 8: 448-455.
12. Meyer JS, Stoica E, Pascu I, Shimazu K, Hart-mann A: Catecholamine concentrations in CSF and plasma of patients with cerebral infarction and haemorrhage. Brain 1973; 96: 277-288.
13. Mutlu GM, Mutlu EA, Factor P: GI complications in patients receiving mechanical ventilation. Chest 2001; 119: 1222-1241.
14. Schaller BJ, Graf R, Jacobs AH: Pathophysi-ological changes of the gastrointestinal tract in ischemic stroke. Am J Gastroenterol 2006; 101: 1655-1665.
15. Hastings PR, Skillman JJ, Bushnell LS, Silen W: Antacid titration in the prevention of acute gastrointestinal bleeding: a controlled, randomized trial in 100 critically ill patients. N Engl J Med 1978; 298: 1041-1045.
16. Cook DJ, Fuller HD, Guyatt GH, Marshall JC, Leasa D, Hall R, Winton TL, Rutledge F, Todd TJ, Roy P, et al: Risk factors for gastrointestinal bleeding in critically ill patients: Canadian Critical Care Trials Group. N Engl J Med 1994; 330: 377-381.
17. Stollman N, Metz DC: Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients. J Crit Care 2005; 20: 35-45.
18. Maynard N, Bihari D, Beale R, Smithies M, Baldock G, Mason R, McColl I: Assessment of splanchnic oxygenation by gastric to-nometry in patients with acute circulatory failure. JAMA 1993; 270: 1203-1210.
19. Lu WY, Rhoney DH, Boling WB, Johnson JD, Smith TC: A review of stress ulcer prophylaxis in the neurosurgical intensive care unit. Neurosurgery 1997; 41: 416-425; discussion 425-426.
20. Violi F, Leo R, Basili S, Ferro D, Cordova C, Balsano F: Association between prolonged bleeding time and gastrointestinal hemorrhage in 102 patients with liver cirrhosis: results of a retrospective study. Haematologica 1994; 79: 61-65.
21. Fujiwara Y, Arakawa T, Higuchi K, Kuroki T: Gastrointestinal lesions in liver cirrhosis (in Japanese). Nippon Rinsho 1998; 56: 2387-2390.
22. Weigert AL, Schafer AI: Uremic bleeding: pathogenesis and therapy. Am J Med Sci 1998; 316: 94-104.
23. Fiaccadori E, Maggiore U, Clima B, Melfa L, Rotelli C, Borghetti A: Incidence, risk factors, and prognosis of gastrointestinal hemorrhage complicating acute renal failure. Kidney Int 2001; 59: 1510-1519.
24. Devlin JW, Ben-Menachem T, Ulep SK, Peters MJ, Fogel RP, Zarowitz BJ: Stress ulcer prophylaxis in medical ICU patients: annual utilization in relation to the incidence of en-doscopically proven stress ulceration. Ann Pharmacother 1998; 32: 869-874.
25. Vorder Bruegge WF, Peura DA: Stress-related mucosal damage: review of drug therapy. J Clin Gastroenterol 1990; 12(suppl 2):S35-S40.
26. Kuo PI, Severino R, Pashkow FJ: Mortality rates and hemorrhagic complications in Asian-Pacific Islanders during treatment of acute myocardial infarction. Am J Cardiol 2004; 94: 644-646, A649.
27. Morimoto T, Fukui T, Lee TH, Matsui K: Application of U.S. Guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan. Am J Med 2004; 117: 459-468.
28. Wang TY, Chen AY, Roe MT, Alexander KP, Newby LK, Smith SC Jr, Bangalore S, Gibler WB, Ohman EM, Peterson ED: Comparison of baseline characteristics, treatment patterns, and in-hospital outcomes of Asian versus non-Asian white Americans with non-ST-segment elevation acute coronary syndromes from the CRUSADE quality improvement initiative. Am J Cardiol 2007; 100: 391-396.
29. Chan FK, Chung SC, Suen BY, Lee YT, Leung WK, Leung VK, Wu JC, Lau JY, Hui Y, Lai MS, Chan HL, Sung JJ: Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001; 344: 967-973.
30. Suerbaum S, Michetti P: Helicobacter pylori infection. N Engl J Med 2002; 347: 1175-1186.
31. Erstad BL, Camamo JM, Miller MJ, Webber AM, Fortune J: Impacting cost and appropriateness of stress ulcer prophylaxis at a university medical center. Crit Care Med 1997; 25: 1678-1684.